Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study

Recurrent infections are signs of a weakened immune system, and can be traced to a lack of vitamins and minerals. The objective of this study was to investigate the effect of a nutriological combination of vitamins, trace elements and phytochemicals on the incidence and duration of influenza-like in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MMW Fortschritte der Medizin 2012-12, Vol.154 Suppl 4, p.115-122
Hauptverfasser: Rösler, D, Fuchs, N, Markolin, G, Edler, B, Kuklinski, B, Kästenbauer, T
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 122
container_issue
container_start_page 115
container_title MMW Fortschritte der Medizin
container_volume 154 Suppl 4
creator Rösler, D
Fuchs, N
Markolin, G
Edler, B
Kuklinski, B
Kästenbauer, T
description Recurrent infections are signs of a weakened immune system, and can be traced to a lack of vitamins and minerals. The objective of this study was to investigate the effect of a nutriological combination of vitamins, trace elements and phytochemicals on the incidence and duration of influenza-like infections. Healthy subjects at risk of increased infection exposure took part in a randomized, double-blind, placebo controlled study, each involving a supplementation period of 12 weeks. The occurrence and severity of influenza-like infections and resort to study medication was documented by diary entries. SF-36 questionnaires to measure the health-related quality of life were completed at the start and end of the study. At final examination compliance was examined with respect to returned study medication, diaries and a questionnaire administered to evaluate the effect, safety, and tolerability of the test substance. Of 100 randomized participants, 80 (38 test treatment and 42 placebo) completed the study according to the protocol. In the test treatment group there were 60 influenza-like infections (1.6 infections/12 weeks), significantly fewer (p = 0.0003) compared with the placebo group with 113 episodes (2.7 infections/12 weeks). Further, the average number of days that the infection lasted was shorter in the test treatment group at 10.0 +/- 6.7 days, which was significantly shorter (p = 0.0003) than the placebo group at 28.5 +/- 13.6 days. The influenza-like symptom score and the mean duration of sick leave did not differ statistically between groups. Participants in the test treatment group assessed the global effectiveness of the test substance significantly better (p < 0.0001) than the participants of the placebo group. At the beginning of the study there was no difference between groups with respect to SF-36 results. However, at the completion of the study 6 of the 8 scales of SF-36 in the test treatment group were significantly better compared with the placebo group. In summary, consumption of the complex nutriological test preparation was associated with a significant reduction in the incidence of influenza-like infections, as well as their duration, and it was associated with significantly improved vitality, social functioning, and psychological well-being.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273657881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1273657881</sourcerecordid><originalsourceid>FETCH-LOGICAL-p560-60b2b87e4515b45178905292ab1c882a6deb527a83f332822f72a419dbf246173</originalsourceid><addsrcrecordid>eNo1kE9LxDAQxXNQ3GXdryA9ejDQJm2SepPFPwsLguy9JM0Uo2lSm1TsHv3kZnWdwwyP-c2DN2doWZRUYEo4W6B1CG95qrImNckv0IJQSlhN8yX6fgE9tdF4l_kuM66zE7iDxNa8w1HC7y5kas5kNrzO0cNXHGUb8aeJsjcOt75XxskjdpuYUTrte3MAfZNpPykLWFnjkhqsbEH5dODi6K0FnYU46fkSnXfSBlif5grtH-73mye8e37cbu52eKhYjlmuiBIcyqqoVGpc1HmV4khVtEIQyTSoinApaJfCCUI6TmRZ1Fp1pGQFpyt0_Wc7jP5jghCb3oQWrJUO_BSagnDKKi5EkdCrEzqpHnQzjKaX49z8v43-AE68ams</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273657881</pqid></control><display><type>article</type><title>Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>ProQuest Central</source><creator>Rösler, D ; Fuchs, N ; Markolin, G ; Edler, B ; Kuklinski, B ; Kästenbauer, T</creator><creatorcontrib>Rösler, D ; Fuchs, N ; Markolin, G ; Edler, B ; Kuklinski, B ; Kästenbauer, T</creatorcontrib><description>Recurrent infections are signs of a weakened immune system, and can be traced to a lack of vitamins and minerals. The objective of this study was to investigate the effect of a nutriological combination of vitamins, trace elements and phytochemicals on the incidence and duration of influenza-like infections. Healthy subjects at risk of increased infection exposure took part in a randomized, double-blind, placebo controlled study, each involving a supplementation period of 12 weeks. The occurrence and severity of influenza-like infections and resort to study medication was documented by diary entries. SF-36 questionnaires to measure the health-related quality of life were completed at the start and end of the study. At final examination compliance was examined with respect to returned study medication, diaries and a questionnaire administered to evaluate the effect, safety, and tolerability of the test substance. Of 100 randomized participants, 80 (38 test treatment and 42 placebo) completed the study according to the protocol. In the test treatment group there were 60 influenza-like infections (1.6 infections/12 weeks), significantly fewer (p = 0.0003) compared with the placebo group with 113 episodes (2.7 infections/12 weeks). Further, the average number of days that the infection lasted was shorter in the test treatment group at 10.0 +/- 6.7 days, which was significantly shorter (p = 0.0003) than the placebo group at 28.5 +/- 13.6 days. The influenza-like symptom score and the mean duration of sick leave did not differ statistically between groups. Participants in the test treatment group assessed the global effectiveness of the test substance significantly better (p &lt; 0.0001) than the participants of the placebo group. At the beginning of the study there was no difference between groups with respect to SF-36 results. However, at the completion of the study 6 of the 8 scales of SF-36 in the test treatment group were significantly better compared with the placebo group. In summary, consumption of the complex nutriological test preparation was associated with a significant reduction in the incidence of influenza-like infections, as well as their duration, and it was associated with significantly improved vitality, social functioning, and psychological well-being.</description><identifier>ISSN: 1438-3276</identifier><identifier>PMID: 23326930</identifier><language>ger</language><publisher>Germany</publisher><subject>Adult ; Antioxidants - therapeutic use ; Antiviral Agents - therapeutic use ; Double-Blind Method ; Drug Combinations ; Female ; Follow-Up Studies ; Humans ; Immunocompetence ; Influenza, Human - immunology ; Influenza, Human - prevention &amp; control ; Male ; Middle Aged ; Phytotherapy ; Plant Extracts - therapeutic use ; Vitamins - therapeutic use</subject><ispartof>MMW Fortschritte der Medizin, 2012-12, Vol.154 Suppl 4, p.115-122</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,33722</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23326930$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rösler, D</creatorcontrib><creatorcontrib>Fuchs, N</creatorcontrib><creatorcontrib>Markolin, G</creatorcontrib><creatorcontrib>Edler, B</creatorcontrib><creatorcontrib>Kuklinski, B</creatorcontrib><creatorcontrib>Kästenbauer, T</creatorcontrib><title>Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study</title><title>MMW Fortschritte der Medizin</title><addtitle>MMW Fortschr Med</addtitle><description>Recurrent infections are signs of a weakened immune system, and can be traced to a lack of vitamins and minerals. The objective of this study was to investigate the effect of a nutriological combination of vitamins, trace elements and phytochemicals on the incidence and duration of influenza-like infections. Healthy subjects at risk of increased infection exposure took part in a randomized, double-blind, placebo controlled study, each involving a supplementation period of 12 weeks. The occurrence and severity of influenza-like infections and resort to study medication was documented by diary entries. SF-36 questionnaires to measure the health-related quality of life were completed at the start and end of the study. At final examination compliance was examined with respect to returned study medication, diaries and a questionnaire administered to evaluate the effect, safety, and tolerability of the test substance. Of 100 randomized participants, 80 (38 test treatment and 42 placebo) completed the study according to the protocol. In the test treatment group there were 60 influenza-like infections (1.6 infections/12 weeks), significantly fewer (p = 0.0003) compared with the placebo group with 113 episodes (2.7 infections/12 weeks). Further, the average number of days that the infection lasted was shorter in the test treatment group at 10.0 +/- 6.7 days, which was significantly shorter (p = 0.0003) than the placebo group at 28.5 +/- 13.6 days. The influenza-like symptom score and the mean duration of sick leave did not differ statistically between groups. Participants in the test treatment group assessed the global effectiveness of the test substance significantly better (p &lt; 0.0001) than the participants of the placebo group. At the beginning of the study there was no difference between groups with respect to SF-36 results. However, at the completion of the study 6 of the 8 scales of SF-36 in the test treatment group were significantly better compared with the placebo group. In summary, consumption of the complex nutriological test preparation was associated with a significant reduction in the incidence of influenza-like infections, as well as their duration, and it was associated with significantly improved vitality, social functioning, and psychological well-being.</description><subject>Adult</subject><subject>Antioxidants - therapeutic use</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Drug Combinations</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunocompetence</subject><subject>Influenza, Human - immunology</subject><subject>Influenza, Human - prevention &amp; control</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Phytotherapy</subject><subject>Plant Extracts - therapeutic use</subject><subject>Vitamins - therapeutic use</subject><issn>1438-3276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE9LxDAQxXNQ3GXdryA9ejDQJm2SepPFPwsLguy9JM0Uo2lSm1TsHv3kZnWdwwyP-c2DN2doWZRUYEo4W6B1CG95qrImNckv0IJQSlhN8yX6fgE9tdF4l_kuM66zE7iDxNa8w1HC7y5kas5kNrzO0cNXHGUb8aeJsjcOt75XxskjdpuYUTrte3MAfZNpPykLWFnjkhqsbEH5dODi6K0FnYU46fkSnXfSBlif5grtH-73mye8e37cbu52eKhYjlmuiBIcyqqoVGpc1HmV4khVtEIQyTSoinApaJfCCUI6TmRZ1Fp1pGQFpyt0_Wc7jP5jghCb3oQWrJUO_BSagnDKKi5EkdCrEzqpHnQzjKaX49z8v43-AE68ams</recordid><startdate>20121217</startdate><enddate>20121217</enddate><creator>Rösler, D</creator><creator>Fuchs, N</creator><creator>Markolin, G</creator><creator>Edler, B</creator><creator>Kuklinski, B</creator><creator>Kästenbauer, T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20121217</creationdate><title>Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study</title><author>Rösler, D ; Fuchs, N ; Markolin, G ; Edler, B ; Kuklinski, B ; Kästenbauer, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p560-60b2b87e4515b45178905292ab1c882a6deb527a83f332822f72a419dbf246173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Antioxidants - therapeutic use</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Drug Combinations</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunocompetence</topic><topic>Influenza, Human - immunology</topic><topic>Influenza, Human - prevention &amp; control</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Phytotherapy</topic><topic>Plant Extracts - therapeutic use</topic><topic>Vitamins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rösler, D</creatorcontrib><creatorcontrib>Fuchs, N</creatorcontrib><creatorcontrib>Markolin, G</creatorcontrib><creatorcontrib>Edler, B</creatorcontrib><creatorcontrib>Kuklinski, B</creatorcontrib><creatorcontrib>Kästenbauer, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>MMW Fortschritte der Medizin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rösler, D</au><au>Fuchs, N</au><au>Markolin, G</au><au>Edler, B</au><au>Kuklinski, B</au><au>Kästenbauer, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study</atitle><jtitle>MMW Fortschritte der Medizin</jtitle><addtitle>MMW Fortschr Med</addtitle><date>2012-12-17</date><risdate>2012</risdate><volume>154 Suppl 4</volume><spage>115</spage><epage>122</epage><pages>115-122</pages><issn>1438-3276</issn><abstract>Recurrent infections are signs of a weakened immune system, and can be traced to a lack of vitamins and minerals. The objective of this study was to investigate the effect of a nutriological combination of vitamins, trace elements and phytochemicals on the incidence and duration of influenza-like infections. Healthy subjects at risk of increased infection exposure took part in a randomized, double-blind, placebo controlled study, each involving a supplementation period of 12 weeks. The occurrence and severity of influenza-like infections and resort to study medication was documented by diary entries. SF-36 questionnaires to measure the health-related quality of life were completed at the start and end of the study. At final examination compliance was examined with respect to returned study medication, diaries and a questionnaire administered to evaluate the effect, safety, and tolerability of the test substance. Of 100 randomized participants, 80 (38 test treatment and 42 placebo) completed the study according to the protocol. In the test treatment group there were 60 influenza-like infections (1.6 infections/12 weeks), significantly fewer (p = 0.0003) compared with the placebo group with 113 episodes (2.7 infections/12 weeks). Further, the average number of days that the infection lasted was shorter in the test treatment group at 10.0 +/- 6.7 days, which was significantly shorter (p = 0.0003) than the placebo group at 28.5 +/- 13.6 days. The influenza-like symptom score and the mean duration of sick leave did not differ statistically between groups. Participants in the test treatment group assessed the global effectiveness of the test substance significantly better (p &lt; 0.0001) than the participants of the placebo group. At the beginning of the study there was no difference between groups with respect to SF-36 results. However, at the completion of the study 6 of the 8 scales of SF-36 in the test treatment group were significantly better compared with the placebo group. In summary, consumption of the complex nutriological test preparation was associated with a significant reduction in the incidence of influenza-like infections, as well as their duration, and it was associated with significantly improved vitality, social functioning, and psychological well-being.</abstract><cop>Germany</cop><pmid>23326930</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1438-3276
ispartof MMW Fortschritte der Medizin, 2012-12, Vol.154 Suppl 4, p.115-122
issn 1438-3276
language ger
recordid cdi_proquest_miscellaneous_1273657881
source MEDLINE; Springer Nature - Complete Springer Journals; ProQuest Central
subjects Adult
Antioxidants - therapeutic use
Antiviral Agents - therapeutic use
Double-Blind Method
Drug Combinations
Female
Follow-Up Studies
Humans
Immunocompetence
Influenza, Human - immunology
Influenza, Human - prevention & control
Male
Middle Aged
Phytotherapy
Plant Extracts - therapeutic use
Vitamins - therapeutic use
title Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A04%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20of%20influenza-like%20infections%20by%20a%20phytoextract-vitamin-combination:%20a%20randomized,%20double-blind,%20placebo-controlled%20study&rft.jtitle=MMW%20Fortschritte%20der%20Medizin&rft.au=R%C3%B6sler,%20D&rft.date=2012-12-17&rft.volume=154%20Suppl%204&rft.spage=115&rft.epage=122&rft.pages=115-122&rft.issn=1438-3276&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1273657881%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1273657881&rft_id=info:pmid/23326930&rfr_iscdi=true